NOTR Stock Overview
Nowtransit Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nowtransit Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.00 |
| 52 Week High | US$9.01 |
| 52 Week Low | US$1.00 |
| Beta | 0.027 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 81.82% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| NOTR | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | 1.0% |
| 1Y | n/a | 2.2% | 21.9% |
Return vs Industry: Insufficient data to determine how NOTR performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how NOTR performed against the US Market.
Price Volatility
| NOTR volatility | |
|---|---|
| NOTR Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NOTR has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NOTR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Darren Lopez | n/a |
Nowtransit Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses. The company markets Be On-Guard Mouth Spray and Nasal Spray; EZ Safer Surface Cleaner; Be On-Guard brain fog support; Active Daily Health Defence 365 for maximum strength brain support; NeuroPro Plus, a patent pending combination of pharmaceutical grade methylene blue and vitamin; TBI-365 to elevate brain health and wellness with pharmaceutical grade methylene blue, glucine, nac and niacinamide; and Metabolism+ to enhance metabolism. It sells its products through Amazon platform; wholesales through online platform; private label sales; and direct sales.
Nowtransit Inc. Fundamentals Summary
| NOTR fundamental statistics | |
|---|---|
| Market cap | US$41.60m |
| Earnings (TTM) | -US$251.50k |
| Revenue (TTM) | US$597.60k |
69.6x
P/S Ratio-165.4x
P/E RatioIs NOTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NOTR income statement (TTM) | |
|---|---|
| Revenue | US$597.60k |
| Cost of Revenue | US$113.19k |
| Gross Profit | US$484.41k |
| Other Expenses | US$735.91k |
| Earnings | -US$251.50k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.006 |
| Gross Margin | 81.06% |
| Net Profit Margin | -42.09% |
| Debt/Equity Ratio | -1,288.1% |
How did NOTR perform over the long term?
See historical performance and comparison